To further confirm the role of CaMKII, JAK-3, and IKK kinase in CSC formation, we investigated the effect of these kinase inhibitors on proportion of breast cancer cells with ALDH activity and CD44high/CD24low-expressing subpopulation in MCF-7 cells. The gene discussed is CAMK2G; the disease is breast cancer.